About
Du holds a Ph.D. in biochemistry from the University of Cincinnati and a B.S. in molecular biology from Jilin University in China. She began her research career at Pfizer in the United States, where she led its global metabolic licensing program from 1994 to 2001. She then co-founded Hutchison MediPharma, serving as its chief executive, and was a co-founder and chief scientific officer of Hutchison China MediTech until 2011. Later she worked at Sequoia Capital China, first as a healthcare partner and then as a venture partner. Other pharmaceutical leaders on Whoo include John Oyler of BeOne Medicines and Julie Kim of Takeda.
Whoo compiled this page from public sources: Zai Lab proxy statement (SEC, April 2026), Zai Lab leadership page, Zai Lab Form 8-K (SEC, November 2026). It is not affiliated with or endorsed by Samantha Du. Are you Samantha Du? Claim this page, or write to [email protected] to correct or remove it. Last updated: 2026-11-18.
Want a page like this? Create yours from your résumé.
Experience
Founder, Chairperson and Chief Executive Officer — Zai Lab
Director since 2014 | Shanghai, China
- Leads a biopharmaceutical company focused on oncology, immunology, neuroscience and infectious disease
- Healthcare Partner 2012 to 2014, Venture Partner 2014 to 2017
- Also co-founder and Chief Scientific Officer of Hutchison China MediTech
- Led the global metabolic licensing program
Healthcare Partner and Venture Partner — Sequoia Capital China
2012 – 2017
Co-founder and CEO — Hutchison MediPharma
2001 – 2011
Researcher — Pfizer
1994 – 2001